(IMAGE)
Caption
At the Technical University of Munich (TUM), Bernhard Küster, Professor of Proteomics and Bioanalytics, and his team are investigating how therapeutic drugs work, which molecular mechanisms play a role in cancer, and how these can be used for individualized approaches in clinical treatment. For this purpose, they work, among other things, with a mass spectrometer. Mass spectrometers generate data at high speed, which is automatically evaluated by computers. Individual results are randomly checked for quality and significance.
Credit
Astrid Eckert / TUM
Usage Restrictions
Free for use in reporting on TUM, with the copyright noted
License
Licensed content